中国生物科技服务(08037)与STELLA PHARMA CORPORATION签署谅解备忘录

智通财经2025-05-08

智通财经APP讯，中国生物科技服务(08037)发布公告，于2025年5月8日，本公司、鹏博(海南)硼中子医疗科技有限公司(鹏博海南)及STELLA PHARMA CORPORATION(Stella Pharma)(统称“订约各方”)订立一份谅解备忘录(谅解备忘录)，有关拟进一步就STEBORONINE®(一种用于硼中子治疗(BNCT)的药物，针对不可切除、局部晚期或局部复发的头颈癌)(硼中子...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2533333531?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-08 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533333531","market":"us","top_or_hot":-1,"title":"中国生物科技服务(08037)与STELLA PHARMA CORPORATION签署谅解备忘录","media":"智通财经","content":"<div>\n<p>智通财经APP讯，中国生物科技服务(08037)发布公告，于2025年5月8日，本公司、鹏 博(海南)硼中子医疗科技有限公司(鹏博海南)及STELLA PHARMA CORPORATION(Stella Pharma)(统称“订约各方”)订立一份谅解备忘录(谅解备忘录)，有关拟进一步就STEBORONINE®(一种用于硼中子治疗(BNCT)的药物，针对不可切除、局部晚期或局部复发的头颈癌)(硼中子...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1291034.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国生物科技服务(08037)与STELLA PHARMA CORPORATION签署谅解备忘录</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国生物科技服务(08037)与STELLA PHARMA CORPORATION签署谅解备忘录\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-08 21:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1291034.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，中国生物科技服务(08037)发布公告，于2025年5月8日，本公司、鹏 博(海南)硼中子医疗科技有限公司(鹏博海南)及STELLA PHARMA CORPORATION(Stella Pharma)(统称“订约各方”)订立一份谅解备忘录(谅解备忘录)，有关拟进一步就STEBORONINE®(一种用于硼中子治疗(BNCT)的药物，针对不可切除、局部晚期或局部复发的头颈癌)(硼中子...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1291034.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1511","symbol_name":"疑似财技股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1291034.html","article_id":"2533333531","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533333531","pubTimestamp":1746710204,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中国生物科技服务 发布公告，于2025年5月8日，本公司、鹏 博(海南)硼中子医疗科技有限公司及STELLA PHARMA CORPORATION订立一份谅解备忘录，有关拟进一步就STEBORONINE在中华人民共和国境内的销售和生产展开合作，作为订约各方持续合作的重要一环。签署谅解备忘录的目的是为了进一步拓展本公司在硼中子治疗产业中的布局。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1511":"疑似财技股","BK1219":"保健护理服务","08037":"中国生物科技服务"},"translate_title":"China Biotech Services (08037) Signs MoU with STELLA PHARMA CORPORATION","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"智通财经APP讯，中国生物科技服务(08037)发布公告，于2025年5月8日，本公司、鹏 博(海南)硼中子医疗科技有限公司(鹏博海南)及STELLA PHARMA CORPORATION(Stella Pharma)(统称“订约各方”)订立一份谅解备忘录(谅解备忘录)，有关拟进一步就STEBORONINE®(一种用于硼中子治疗(BNCT)的药物，针对不可切除、局部晚期或局部复发的头颈癌)(硼中子治疗药物)在中华人民共和国(中国，就本公告而言，不包括香港、澳门及台湾)境内的销售和生产展开合作，作为订约各方持续合作的重要一环。签署谅解备忘录的目的是为了进一步拓展本公司在硼中子治疗产业中的布局。通过在中国海南自由贸易港博鳌乐城国际医疗旅游先行区(博鳌乐城先行区)建造硼中子癌症治疗中心(硼中子中心)，引进硼药物实施硼中子治疗并将其实现商业化的基础上，拟通过进一步授权合作的方式，将硼中子治疗药物生产国产化，从而可以更大规模生产及销售硼中子治疗药物。通过谅解备忘录，将加快本集团在硼中子治疗上游产业的布局，增强本集团未来在硼中子治疗产业中的竞争力及推动硼中子治疗在中国更多城市应用于癌症治疗领域。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2533333531","isCrawlerRequest":true}